Fsd Pharma Inc Cl B
(NQ:
HUGE
)
0.0899
UNCHANGED
Last Price
Updated: 4:00 PM EDT, Aug 14, 2024
Add to My Watchlist
Quote
Overview
Detailed Quote
Charting
Historical Prices
News
All News
News Headlines
Press Releases
Research
Quarterly Reports
Insider Filings
Other Filings
Headline News about Fsd Pharma Inc Cl B
< Previous
1
2
3
Next >
Shark Tank's Kevin Harrington Will Provide Strategic Guidance To Major Psychedelics Company
February 28, 2023
Psychedelics biopharma company FSD Pharma Inc. (NASDAQ: HUGE)’s advisory board has a new member: the iconic entrepreneur and inventor of the infomercial Kevin Harrington.
Via
Benzinga
Psychedelics For Alcohol Use Disorder: Awakn Opens European Clinic, FSD Launches R&D Program
February 14, 2023
Awakn Opens Fourth European Clinic, Norway Takes Center Stage
Via
Benzinga
6 Psychedelics Companies Take Action: Here Are The Latest, Major Announcements
January 10, 2023
Second week of 2023, and business is up and running. Let’s take a look at the announcements shared by some of the companies in the psychedelics space.
Via
Benzinga
FSD Pharma Closes CA$16.4M Sale Of Ontario Cannabis Processing Facility, Here's What's Next
May 10, 2022
FSD Pharma Inc. (NASDAQ: HUGE) (CSE: HUGE) (FRE: 0K9A) has closed the sale of the company’s former cannabis processing facility located in Cobourg, Ontario, Canada, for gross proceeds of CA$16.4...
Via
Benzinga
Psyched: Elon Musk Praises Psychedelics Over Antidepressants, Field Trip To Split In Two, Colorado MDMA Bill Moves Forward
May 02, 2022
The world’s richest man gave another public nod to psychedelics medicine in favor of traditional mental health solutions.
Via
Benzinga
FSD Pharma Shares Slightly Up On Agreement To Sell Cannabis Facility For $12.9M
February 25, 2022
FSD Pharma Inc. (NASDAQ:HUGE) (CSE:
Via
Benzinga
Stocks That Hit 52-Week Lows On Friday
June 24, 2022
On Friday, 61 companies hit new 52-week lows.
Via
Benzinga
FSD Pharma Enters Agreement With Tekkfund Capital Corp To Develop Business
May 02, 2022
FSD Pharma Inc. (NASDAQ: HUGE) entered into an agreement with Tekkfund Capital Corp to structure and assist “with certain business development strategies.”
Via
Benzinga
Cannabis Stocks That Moved On News That Federal Cannabis Legalization Bill Heads To House For Vote Next Week
March 24, 2022
The House of Representatives intends to vote on a bill to federally legalize cannabis for the second time in history next week, congressi...
Via
Benzinga
64 Biggest Movers From Friday
March 28, 2022
Gainers Clever Leaves Holdings Inc. (NASDAQ: CLVR) shares surged 143% to settle at $3.84 on Friday after the company reported better-than-expected Q4 sales results and reaffirmed...
Via
Benzinga
FSD Pharma Unveils Newly Designed Website
January 20, 2022
This post contains sponsored advertising content. This content is for informational purposes only and not intended to be investing advice. FSD Pharma (NASDAQ: HUGE) (CSE: HUGE) (...
Via
Benzinga
93 Biggest Movers From Friday
February 28, 2022
Gainers Inspirato Incorporated (NASDAQ: ISPO) shares surged 50.5% to close at $54.90. Guardforce AI Co., Limited (NASDAQ: GFAI) jumped 45.4% to settle at $0.5979 on Friday. EF...
Via
Benzinga
Stocks That Hit 52-Week Lows On Monday
February 07, 2022
On Monday, 71 stocks hit new 52-week lows. Noteable 52-Week Lows: 3M (NYSE:MMM) was the biggest company in terms of market cap to set a new 52-week low. OceanPal (...
Via
Benzinga
FSD Pharma Board Member Named to the Order of Canada
January 18, 2022
This post contains sponsored advertising content. This content is for informational purposes only and not intended to be investing advice. FSD Pharma (NASDAQ: HUGE) (CSE: HUGE) (...
Via
Benzinga
FSD Pharma Inc. Board Approves Share Repurchase Program
December 30, 2021
FSD Pharma (NASDAQ: HUGE), a life sciences holding company dedicated to building a portfolio of assets and biotech solutions, is repurchasing up to 2 million company shares. The...
Via
Benzinga
Mobile Clinics for Mental Health Treatments Reportedly Launching in Major Cities Across the U.S.
December 28, 2021
Image provided by Unsplash The following post was written and/or published as a collaboration between Benzinga’s in-house sponsored content team and a financial partner of...
Via
Benzinga
FSD Pharma Announces Establishment of Advisory Board, Strategic Appointments
December 23, 2021
FSD Pharma (NASDAQ: HUGE), a life sciences holding company dedicated to building a portfolio of assets and biotech solutions, today announced that it has formed a regulatory...
Via
Benzinga
FSD Pharma Shares Preclinical Data Demonstrating Positive Effects of Lucid-MS in Treating
December 23, 2021
FSD Pharma (NASDAQ: HUGE) (CSE: HUGE) (FRA: 0K9), a life sciences holding company dedicated to building a portfolio of assets and biotech solutions, today shared preclinical data...
Via
Benzinga
Psyched: Cybin Gets $9 Price Target, FSD Pharma Acquires Lucid, New Trials From Psilera, Awakn, PharmaDrug And Braxia, California Bill Put On Hold
August 30, 2021
Contents
Via
Benzinga
54 Biggest Movers From Yesterday
August 26, 2021
Gainers Regencell Bioscience Holdings Limited (NASDAQ: RGC) shares jumped 202.8% to settle at $46.33 on Wednesday after gaining over 11% on Tuesday. Regencell Bioscience recently...
Via
Benzinga
Nasdaq-listed FSD Pharma To Advance Psychedelics Pipeline With $9 Million Acquisition Of Lucid Psycheceuticals
August 25, 2021
FSD Pharma Inc. (NASDAQ:HUGE) (CSE:
Via
Benzinga
FSD Pharma To Buy Canadian Psychedelic Pharmaceutical Firm
August 25, 2021
FSD Pharma Inc (NASDAQ: HUGE) shares rebounded after falling in premarket on acquiring a Canada-based psychedelic pharmaceutical company. Related: See Why FSD Pharma...
Via
Benzinga
36 Stocks Moving In Wednesday's Mid-Day Session
August 25, 2021
Gainers Locust Walk Acquisition Corp. (NASDAQ: LWAC) shares jumped 188% to $25.34 after the company announced stockholders approved a business combination with eFFECTOR...
Via
Benzinga
See Why FSD Pharma Terminated COVID-19 Trial
August 25, 2021
FSD Pharma Inc (NASDAQ: HUGE) will terminate the Phase 2 trial of ultra-micronized palmitoylethanolamide (PEA), or FSD-201, for COVID-19. FSD-201 works by...
Via
Benzinga
Exposures
COVID-19
The Daily Biotech Pulse: Lilly Strikes $1.6B R&D Collaboration, FSD Pulls Plug On COVID-19 Program, Cassava Sinks On Questions About Alzheimer's Drug
August 25, 2021
ere's a roundup of top developments in the biotech space over the last 24 hours. Scaling The Peaks (Biotech Stocks Hitting 52-week Highs Aug. 24) Agenus Inc. (NASDAQ: AGEN)...
Via
Benzinga
Exposures
COVID-19
21 Stocks Moving in Wednesday's Pre-Market Session
August 25, 2021
Gainers Regencell Bioscience Holdings Limited (NASDAQ: RGC) rose 40.1% to $21.43 in pre-market trading after gaining over 11% on Tuesday. Regencell Bioscience recently reported...
Via
Benzinga
64 Biggest Movers From Friday
June 07, 2021
Gainers Senseonics Holdings, Inc. (NYSE: SENS) jumped 42% to settle at $2.91 on Friday after the company disclosed results from a PROMISE study evaluating its Eversense CGM...
Via
Benzinga
40 Stocks Moving In Friday's Mid-Day Session
June 04, 2021
Gainers SemiLEDs Corporation (NASDAQ: LEDS) shares jumped 68.8% to $25.49 after gaining 23% on Thursday. Senseonics Holdings, Inc. (NYSE: SENS) gained 26% to $2.5817 after the...
Via
Benzinga
12 Health Care Stocks Moving In Thursday's After-Market Session
April 22, 2021
Gainers Ocugen (NASDAQ:OCGN) stock moved upwards by 7.1% to $9.95 during Thursday's after-market session. At the close, Ocugen's trading volume reached 7.6 million shares...
Via
Benzinga
12 Health Care Stocks Moving In Monday's After-Market Session
April 12, 2021
Gainers Intec Pharma (NASDAQ:NTEC) shares increased by 7.67% to $4.35 during Monday's after-market session. Intec Pharma's trading volume hit 412 shares by close,...
Via
Benzinga
< Previous
1
2
3
Next >
Data & News supplied by
www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy
and
Terms and Conditions
.